Ravi Paluri to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Ravi Paluri has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
0.046
-
Jamy O, Innis-Shelton R, Bal S, Paluri R, Salzman D, Di Stasi A, Costa L, Meredith R, Lamb L, Minagawa K, Mineishi S, Saad A. Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation. Am J Hematol. 2021 Oct 01; 96(10):E396-E398.
Score: 0.046